Journal article
Impact of pre-adapted HIV transmission
Nature medicine, Vol.22(6), pp.606-613
06/01/2016
DOI: 10.1038/nm.4100
PMCID: PMC4899163
PMID: 27183217
Abstract
Human leukocyte antigen class I (HLA)-restricted CD8(+) T lymphocyte (CTL) responses are crucial to HIV-1 control. Although HIV can evade these responses, the longer-term impact of viral escape mutants remains unclear, as these variants can also reduce intrinsic viral fitness. To address this, we here developed a metric to determine the degree of HIV adaptation to an HLA profile. We demonstrate that transmission of viruses that are pre-adapted to the HLA molecules expressed in the recipient is associated with impaired immunogenicity, elevated viral load and accelerated CD4(+) T cell decline. Furthermore, the extent of pre-adaptation among circulating viruses explains much of the variation in outcomes attributed to the expression of certain HLA alleles. Thus, viral pre-adaptation exploits 'holes' in the immune response. Accounting for these holes may be key for vaccine strategies seeking to elicit functional responses from viral variants, and to HIV cure strategies that require broad CTL responses to achieve successful eradication of HIV reservoirs.
Details
- Title: Subtitle
- Impact of pre-adapted HIV transmission
- Creators
- Jonathan M Carlson - Microsoft (United States)Victor Y Du - University of Alabama at BirminghamNico Pfeifer - National University of SingaporeAnju Bansal - University of Alabama at BirminghamVincent Y F Tan - Max Planck Institute for InformaticsKaren Power - Ragon Institute of MGH, MIT and HarvardChanson J Brumme - AIDS VancouverAnat Kreimer - Max Planck Institute for InformaticsCharles E DeZiel - Microsoft (United States)Nicolo Fusi - Microsoft (United States)Malinda Schaefer - Emory UniversityMark A Brockman - Simon Fraser UniversityJill Gilmour - Imperial College LondonMatt A Price - University of California, San FranciscoWilliam Kilembe - Rwanda Zambia HIV Research GroupRichard Haubrich - Gilead Sciences (United States)Mina John - Royal Perth HospitalSimon Mallal - Vanderbilt UniversityRoger Shapiro - Harvard UniversityJohn Frater - Murdoch UniversityP Richard Harrigan - AIDS VancouverThumbi Ndung'u - Max Planck Institute for Infection BiologySusan Allen - Emory UniversityDavid Heckerman - Microsoft (United States)John Sidney - La Jolla Institute for ImmunologyTodd M Allen - Ragon Institute of MGH, MIT and HarvardPhilip J R Goulder - University of OxfordZabrina L Brumme - Simon Fraser UniversityEric Hunter - Emory UniversityPaul A Goepfert - University of Alabama at Birmingham
- Resource Type
- Journal article
- Publication Details
- Nature medicine, Vol.22(6), pp.606-613
- DOI
- 10.1038/nm.4100
- PMID
- 27183217
- PMCID
- PMC4899163
- NLM abbreviation
- Nat Med
- ISSN
- 1078-8956
- eISSN
- 1546-170X
- Grant note
- UM1 AI068614 / NIAID NIH HHS P30 AI050409 / NIAID NIH HHS Wellcome Trust Howard Hughes Medical Institute U01 AI068636 / NIAID NIH HHS UM1 AI068635 / NIAID NIH HHS P30 AI027767 / NIAID NIH HHS P30 AI110527 / NIAID NIH HHS R01 AI046995 / NIAID NIH HHS U01 AI066454 / NIAID NIH HHS R37 AI051231 / NIAID NIH HHS R01 AI064060 / NIAID NIH HHS MR/L006588/1 / Medical Research Council WT104748MA / Wellcome Trust P01 AI074415 / NIAID NIH HHS R01 AI071906 / NIAID NIH HHS P51 OD011132 / NIH HHS UM1 AI068634 / NIAID NIH HHS R56 AI098551 / NIAID NIH HHS R01 AI112566 / NIAID NIH HHS
- Language
- English
- Date published
- 06/01/2016
- Academic Unit
- Obstetrics and Gynecology
- Record Identifier
- 9984697042902771
Metrics
6 Record Views